Schertzer and his research team are using experimental and preclinical approaches to understand the link between the immune and metabolic systems. They will also examine how existing drugs impact blood glucose.
By understanding how our bodies interact with bacteria and therapeutic drugs during obesity, and how inflammation is triggered, Schertzer's research team aims to improve the safety and success of existing therapies and promote the development of new and innovative treatments for obesity-related diseases.
No related news for this person
Department of Biochemistry and Biomedical Sciences
McMaster Children's Hospital 1280 Main St W HSC - 4N59 Hamilton, Ontario, Canada L8S 4K1
Monday to Friday 8:30am to 4:30pm
Phone: 905-525-9140 ext. 22065 Fax: 905-522-9033
The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at firstname.lastname@example.org.